Abstract:Background: Studies have shown inconsistent associations between serum uric acid (SUA) levels and mortality in peritoneal dialysis (PD) patients. We conducted this meta-analysis to determine whether SUA levels were associated with cardiovascular or all-cause mortality in PD patients. Methods: PubMed, Embase, Web of Science, the Cochrane Library, CNKI, VIP, Wanfang Database, and trial registry databases were systematically searched up to April 11, 2021. Cohort studies of SUA levels and cardiovascular or all-cause mortality in PD patients were obtained. Random effect models were used to calculate the pooled adjusted hazard ratio ( HR ) and corresponding 95% confidence interval ( CI ). Sensitivity analyses were conducted to assess the robustness of the pooled results. Subgroup analyses and meta-regression analyses were performed to explore the sources of heterogeneity. Funnel plots, Begg's tests, and Egger's tests were conducted to evaluate potential publication bias. The GRADE approach was used to rate the certainty of evidence. This study was registered with PROSPERO, CRD42021268739. Results: Seven studies covering 18,113 PD patients were included. Compared with the middle SUA levels, high SUA levels increased the risk of all-cause mortality ( HR = 1.74, 95% CI : 1.26–2.40, I 2 = 34.8%, τ 2 = 0.03), low SUA levels were not statistically significant with the risk of all-cause or cardiovascular mortality ( HR = 1.04, 95% CI : 0.84–1.29, I 2 = 43.8%, τ 2 = 0.03; HR = 0.89, 95% CI : 0.65–1.23, I 2 = 36.3%, τ 2 = 0.04; respectively). Compared with the low SUA levels, high SUA levels were not statistically associated with an increased risk of all-cause or cardiovascular mortality ( HR = 1.19, 95% CI : 0.59–2.40, I 2 = 88.2%, τ 2 = 0.44; HR = 1.22, 95% CI : 0.39–3.85, I 2 = 89.3%, τ 2 = 0.92; respectively). Conclusion: Compared with middle SUA levels, high SUA levels are associated with an increased risk of all-cause mortality in PD patients. SUA levels may not be associated with cardiovascular mortality. More high-level studies, especially randomized controlled trials, are needed to determine the association between SUA levels and cardiovascular or all-cause mortality in PD patients. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021268739 , identifier: CRD42021268739.

Parathyroid hormone, cardiovascular and all-cause mortality: A meta-analysis

High Alkaline Phosphatase and Low Intact Parathyroid Hormone Associate with Worse Clinical Outcome in Peritoneal Dialysis Patients

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Association between primary hyperparathyroidism and cardiovascular outcomes: A systematic review and meta-analysis

Parathyroid Hormone and Bone Mineral Density: a Mendelian Randomization Study.

The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients.

Associations of serum alkaline phosphatase level with all-cause and cardiovascular mortality in the general population

Associations of dietary protein intake with all-cause, cardiovascular disease and cancer mortality: a systematic review and meta-analysis of cohort studies

High Serum Phosphate Is Associated with Cardiovascular Mortality and Subclinical Coronary Atherosclerosis: Systematic Review and Meta-Analysis

Abstract 4139937: Plant-Based Diet and All-Cause and Cause-Specific Mortality among Patients with Cardiovascular Disease: A Population-Based Cohort Study

Associations of Serum 25(OH)D, PTH, and -CTX Levels with All-Cause Mortality in Chinese Community-Dwelling Centenarians

Association Between Parathyroid Hormone-Related Peptide Levels and Mortality in Patients With Malignancy

Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis

The serum uric acid-to-high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality: a cross-sectional study

Serum Uric Acid and Cardiovascular or All-Cause Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis

Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Disease in Hemodialysis Patients: The USRDS Waves 1, 3, and 4 Study

PTH Serum Levels and Mortality Risk among Incident Hemodialysis Patients

Dietary Calcium Intake and Mortality Risk from Cardiovascular Disease and All Causes: a Meta-Analysis of Prospective Cohort Studies

Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis

Association between serum 25-hydroxyvitamin D and vitamin D dietary supplementation and risk of all-cause and cardiovascular mortality among adults with hypertension

Circulating Vitamin D Level and Mortality in Prostate Cancer Patients: a Dose–response Meta-Analysis